{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:38:49Z","timestamp":1791585529365,"version":"4.3.4"},"reference-count":84,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Guideline-based strategies to prevent chronic kidney disease (CKD) progression and complications are available, yet their implementation in clinical practice is uncertain. We aimed to synthesise the available evidence on the concordance of CKD care with clinical guidelines to identify gaps and inform future CKD care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Systematic review and meta-analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data sources, participants, and outcomes<\/jats:title>\n                  <jats:p>We systematically searched MEDLINE (OVID), EMBASE (OVID) and CINAHL (EBSCOhost) (to 18 July 2025) for observational studies of adults with CKD reporting data on the quality of CKD care. We assessed data on quality indicators of CKD care across domains that related to patient monitoring (glomerular filtration rate and albuminuria), medications use (ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), statins) and treatment targets (blood pressure (BP) and HbA1c). Pooled estimates (95%\u2009CI) of the percentage of patients who met the quality indicators for CKD care were estimated using random effects model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>59 studies across 24 countries, including a total of 3 003 641 patients with CKD, were included. Across studies, 81.3% (95% CI: 75% to 87.6%) of patients received eGFR monitoring, 47.4% (95% CI: 40.0% to 54.7%) had albuminuria testing, and 90% (95% CI: 84.3% to 95.9%) had BP measured. ACEIs\/ARBs were prescribed among 56.7% (95% CI: 51.5% to 62%), and statins among 56.6% (95% CI: 48.9% to 64.3%) of patients. BP (systolic BP \u2264140\/90\u2009mm Hg) and HbA1c (&lt;7%) targets were achieved in 56.5% (95% CI: 48.5% to 64.6%) and 43.5% (95% CI: 39.4% to 47.6%) of patients, respectively. Subgroup analysis indicated higher rates of proteinuria testing among patients with diabetes (52.2%) compared with those without (31.3%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Current evidence shows substantial variation in CKD care quality globally. Guideline-concordant care varied according to quality measures and across patient groups, with gaps in indicators like albuminuria testing. These findings underscore the need for effective quality improvement strategies to address gaps in CKD care, including increased albuminuria testing for risk stratification, together with systematic measures for monitoring care quality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42023391749.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-102044","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:20:55Z","timestamp":1756999255000},"page":"e102044","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Quality of care for people with chronic kidney disease: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-7814","authenticated-orcid":false,"given":"Daniel Bekele","family":"Ketema","sequence":"first","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia"},{"name":"School of Public Health, College of Medicine and Health Science, Debre Markos University College of Health Science, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wallace","sequence":"additional","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Western Health Chronic Disease Alliance, Western Health, Footscray, VIC, Australia"},{"name":"Faculty of Medicine and Health, University of Melbourne, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Workagegnehu","family":"Hailu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Gondar College of Medicine and Health Sciences, Gondar, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V","family":"Badve","sequence":"additional","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Renal Medicine, St. George Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ronksley","sequence":"additional","affiliation":[{"name":"Community Health Sciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon L","family":"Neuen","sequence":"additional","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine & Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[{"name":"School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil"},{"name":"ClinEpi Program, Arbor Research Collaborative for Health, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Liverpool Clinical School, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sradha","family":"Kotwal","sequence":"additional","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Prince of Wales Hospital NCCC, Randwick, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohina","family":"Joshi","sequence":"additional","affiliation":[{"name":"School of Population Health, University of New South Wales Faculty of Medicine, Sydney, New South Wales, Australia"},{"name":"The George Institute for Global Health, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jun","sequence":"additional","affiliation":[{"name":"Renal and Metabolic Program, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"2025100512102035000_15.9.e102044.1","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-021-02597-3","article-title":"Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019","volume":"23","author":"Ke","year":"2022","journal-title":"BMC Nephrol"},{"key":"2025100512102035000_15.9.e102044.2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002343"},{"key":"2025100512102035000_15.9.e102044.3","first-page":"888","article-title":"Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease","volume":"104","author":"Eckardt","year":"2023","journal-title":"KDIGO"},{"key":"2025100512102035000_15.9.e102044.4","first-page":"i","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Levey","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2025100512102035000_15.9.e102044.5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31694-5"},{"key":"2025100512102035000_15.9.e102044.6","doi-asserted-by":"publisher","DOI":"10.1016\/J.KINT.2023.10.018"},{"key":"2025100512102035000_15.9.e102044.7","unstructured":"Bello A , Okpechi I , Levin A , et al . A report by the international society of nephrology: an assessment of global kidney health care status focussing on capacity, availability, accessibility, affordability and outcomes of kidney disease. International Society of Nephrology; 2023. Available: https:\/\/doi. org\/10.1001\/jama"},{"key":"2025100512102035000_15.9.e102044.8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00040-6"},{"key":"2025100512102035000_15.9.e102044.9","doi-asserted-by":"crossref","unstructured":"Moiseev VC , Mukhin NA , Smirnov AV , et al . CARDIOVASCULAR RISK AND CHRONIC KIDNEY DISEASE: CARDIO-NEPHROPROTECTION STRATEGIES. Russ J Cardiol 2014;7\u201337. doi:10.15829\/1560-4071-2014-8-7-37","DOI":"10.15829\/1560-4071-2014-8-7-37"},{"key":"2025100512102035000_15.9.e102044.10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/dme.13014","article-title":"Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry","volume":"33","author":"Luk","year":"2016","journal-title":"Diabet Med"},{"key":"2025100512102035000_15.9.e102044.11","first-page":"654","article-title":"Management of chronic kidney disease in Taiwan: room for quality improvement","volume":"22","author":"Kuo","year":"2009","journal-title":"J Nephrol"},{"key":"2025100512102035000_15.9.e102044.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272662","article-title":"Quality and variation of care for chronic kidney disease in Swiss general practice: A retrospective database study","volume":"17","author":"J\u00e4ger","year":"2022","journal-title":"PLoS ONE"},{"key":"2025100512102035000_15.9.e102044.13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.08720816","article-title":"A Population-Based Analysis of Quality Indicators in CKD","volume":"12","author":"Manns","year":"2017","journal-title":"CJASN"},{"key":"2025100512102035000_15.9.e102044.14","doi-asserted-by":"publisher","DOI":"10.1159\/000066296"},{"key":"2025100512102035000_15.9.e102044.15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.10704","article-title":"Quality of Chronic Kidney Disease Management in Canadian Primary Care","volume":"2","author":"Bello","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025100512102035000_15.9.e102044.16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ekir.2020.11.039","article-title":"Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries","volume":"6","author":"Stengel","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025100512102035000_15.9.e102044.17","unstructured":"MOOSE group . MOOSE (meta-analyses of observational studies in epidemiology) checklist. 2024. Available: https:\/\/legacyfileshare.elsevier.com\/promis_misc\/ISSM_MOOSE_Checklist.pdf"},{"key":"2025100512102035000_15.9.e102044.18","doi-asserted-by":"crossref","first-page":"100046","DOI":"10.1016\/j.glmedi.2023.100046","article-title":"Formulating research questions for evidence-based studies","volume":"2","author":"Hosseini","year":"2024","journal-title":"J Med Surg Public Health"},{"key":"2025100512102035000_15.9.e102044.19","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"2025100512102035000_15.9.e102044.20","unstructured":"Covidence . Covidence: systematic review software. 2023. Available: https:\/\/www.covidence.org"},{"key":"2025100512102035000_15.9.e102044.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11325-z","article-title":"Kappa statistic considerations in evaluating inter-rater reliability between two raters: which, when and context matters","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"key":"2025100512102035000_15.9.e102044.22","unstructured":"Wells GA , Shea B , O\u2019Connell D , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"key":"2025100512102035000_15.9.e102044.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.019"},{"key":"2025100512102035000_15.9.e102044.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007525","article-title":"Prevalence of chronic kidney disease in Asia: a systematic review and analysis","volume":"7","author":"Liyanage","year":"2022","journal-title":"BMJ Glob Health"},{"key":"2025100512102035000_15.9.e102044.25","unstructured":"Schwarzer G . Meta: general package for meta-analysis. Vienna, Austria R Foundation for Statistical Computing; 2024."},{"key":"2025100512102035000_15.9.e102044.26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CM9.0000000000002814","article-title":"Fixed-effect and random-effects models in meta-analysis","volume":"137","author":"Zhai","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"2025100512102035000_15.9.e102044.27","doi-asserted-by":"crossref","unstructured":"Borenstein M , Hedges LV , Higgins JP , et al . Introduction to meta-analysis. John wiley & sons, 2021.","DOI":"10.1002\/9781119558378"},{"key":"2025100512102035000_15.9.e102044.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025100512102035000_15.9.e102044.29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12882-015-0194-2","article-title":"An observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study","volume":"16","author":"Arora","year":"2015","journal-title":"BMC Nephrol"},{"key":"2025100512102035000_15.9.e102044.30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2369-15-70","article-title":"Electronic problem list documentation of chronic kidney disease and quality of care","volume":"15","author":"Samal","year":"2014","journal-title":"BMC Nephrol"},{"key":"2025100512102035000_15.9.e102044.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1523-6"},{"key":"2025100512102035000_15.9.e102044.32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.xkme.2021.02.008","article-title":"Neighborhood Socioeconomic Status and Quality of Kidney Care: Data From Electronic Health Records","volume":"3","author":"Ghazi","year":"2021","journal-title":"Kidney Med"},{"key":"2025100512102035000_15.9.e102044.33","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.mayocp.2020.12.038","article-title":"Barriers to ACEI\/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study","volume":"96","author":"McCoy","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2025100512102035000_15.9.e102044.34","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12325-023-02482-5","article-title":"Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study","volume":"40","author":"Tangri","year":"2023","journal-title":"Adv Ther"},{"key":"2025100512102035000_15.9.e102044.35","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2021.08.010","article-title":"The Kidney Failure Risk Equation Score and CKD Care Delivery Measures: A Cross-sectional Study","volume":"4","author":"Ahmed","year":"2022","journal-title":"Kidney Med"},{"key":"2025100512102035000_15.9.e102044.36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ndt\/gfac140","article-title":"High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database","volume":"38","author":"Fried","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025100512102035000_15.9.e102044.37","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-1156-2","article-title":"Validating laboratory defined chronic kidney disease in the electronic health record for patients in primary care","volume":"20","author":"Frigaard","year":"2019","journal-title":"BMC Nephrol"},{"key":"2025100512102035000_15.9.e102044.38","first-page":"620","article-title":"Adherence to K\/DOQI practice guidelines for bone metabolism and disease","volume":"13","author":"Hoy","year":"2007","journal-title":"Am J Manag Care"},{"key":"2025100512102035000_15.9.e102044.39","doi-asserted-by":"publisher","DOI":"10.1159\/000360306"},{"key":"2025100512102035000_15.9.e102044.40","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03830318"},{"key":"2025100512102035000_15.9.e102044.41","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1281713"},{"key":"2025100512102035000_15.9.e102044.42","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0154-x","article-title":"Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis","volume":"16","author":"Samal","year":"2015","journal-title":"BMC Nephrol"},{"key":"2025100512102035000_15.9.e102044.43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clinthera.2014.11.011","article-title":"Utilization Patterns of Antihypertensive Drugs Among the Chronic Kidney Disease Population in the United States: A Cross-sectional Analysis of the National Health and Nutrition Examination Survey","volume":"37","author":"Sonawane","year":"2015","journal-title":"Clin Ther"},{"key":"2025100512102035000_15.9.e102044.44","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s11606-022-07863-0","article-title":"Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease","volume":"38","author":"Rikin","year":"2023","journal-title":"J Gen Intern Med"},{"key":"2025100512102035000_15.9.e102044.45","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.07.052"},{"key":"2025100512102035000_15.9.e102044.46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11606-015-3452-x","article-title":"Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease","volume":"31","author":"Ricardo","year":"2016","journal-title":"J Gen Intern Med"},{"key":"2025100512102035000_15.9.e102044.47","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00060119"},{"key":"2025100512102035000_15.9.e102044.48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.27014","article-title":"Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019","volume":"4","author":"Chu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025100512102035000_15.9.e102044.49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18169","article-title":"Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry","volume":"2","author":"Tuttle","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025100512102035000_15.9.e102044.50","doi-asserted-by":"publisher","DOI":"10.1177\/1062860608314985"},{"key":"2025100512102035000_15.9.e102044.51","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33910"},{"key":"2025100512102035000_15.9.e102044.52","first-page":"e107","article-title":"Management of aboriginal and nonaboriginal people with chronic kidney disease in Quebec: quality-of-care indicators","volume":"58","author":"Patapas","year":"2012","journal-title":"Can Fam Physician"},{"key":"2025100512102035000_15.9.e102044.53","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14861","article-title":"Association of Specialist Physician Payment Model With Visit Frequency, Quality, and Costs of Care for People With Chronic Disease","volume":"2","author":"Quinn","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025100512102035000_15.9.e102044.54","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.376"},{"key":"2025100512102035000_15.9.e102044.55","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117703059","article-title":"Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, Canada","volume":"4","author":"Nash","year":"2017","journal-title":"Can J Kidney Health Dis"},{"key":"2025100512102035000_15.9.e102044.56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177949","article-title":"Variations in achievement of evidence-based, high-impact quality indicators in general practice: An observational study","volume":"12","author":"Willis","year":"2017","journal-title":"PLoS ONE"},{"key":"2025100512102035000_15.9.e102044.57","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X713105"},{"key":"2025100512102035000_15.9.e102044.58","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.8.443"},{"key":"2025100512102035000_15.9.e102044.59","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx280"},{"key":"2025100512102035000_15.9.e102044.60","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmi026"},{"key":"2025100512102035000_15.9.e102044.61","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv101"},{"key":"2025100512102035000_15.9.e102044.62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000490769","article-title":"Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study","volume":"140","author":"Cozzolino","year":"2018","journal-title":"Nephron"},{"key":"2025100512102035000_15.9.e102044.63","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.08.022"},{"key":"2025100512102035000_15.9.e102044.64","doi-asserted-by":"crossref","DOI":"10.1136\/fmch-2021-001006","article-title":"Using electronic medical record data to assess chronic kidney disease, type 2 diabetes and cardiovascular disease testing, recognition and management as documented in Australian general practice: a cross-sectional analysis","volume":"10","author":"Jones","year":"2022","journal-title":"Fam Med Community Health"},{"key":"2025100512102035000_15.9.e102044.65","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-017-0493-x","article-title":"Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study","volume":"18","author":"Lo","year":"2017","journal-title":"BMC Nephrol"},{"key":"2025100512102035000_15.9.e102044.66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.31128\/AJGP-07-18-4630","article-title":"Chronic kidney disease monitoring in Australian general practice","volume":"48","author":"Khanam","year":"2019","journal-title":"Aust J Gen Pract"},{"key":"2025100512102035000_15.9.e102044.67","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.13636","article-title":"Quality of care and prescription patterns among patients with diabetic kidney disease-a large-scale cohort study from Taiwanese clinics","volume":"10","author":"Tsai","year":"2022","journal-title":"PeerJ"},{"key":"2025100512102035000_15.9.e102044.68","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.ajkd.2017.05.020","article-title":"Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes","volume":"70","author":"Wu","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2025100512102035000_15.9.e102044.69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01028.x"},{"key":"2025100512102035000_15.9.e102044.70","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-022-08691-y","article-title":"Monitoring and management of chronic kidney disease in ambulatory care - analysis of clinical and claims data from a population-based study","volume":"22","author":"Weckmann","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2025100512102035000_15.9.e102044.71","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq184"},{"key":"2025100512102035000_15.9.e102044.72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/02813432.2015.1132885","article-title":"Quality of chronic kidney disease management in primary care: a retrospective study","volume":"34","author":"Van Gelder","year":"2016","journal-title":"Scand J Prim Health Care"},{"key":"2025100512102035000_15.9.e102044.73","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/MLR.0000000000001301","article-title":"Quality of Care in Chronic Kidney Disease and Incidence of End-stage Renal Disease in Older Patients: A Cohort Study","volume":"58","author":"Fukuma","year":"2020","journal-title":"Med Care"},{"key":"2025100512102035000_15.9.e102044.74","doi-asserted-by":"crossref","unstructured":"Samaan F , Fernandes DE , Kirsztajn GM , et al . Quality indicators for primary health care in chronic kidney disease in the public service of a city in the State of S\u00e3o Paulo, Brazil. Cad Saude Publica 2022;38. doi:10.1590\/0102-311X00090821","DOI":"10.1590\/0102-311x00090821"},{"key":"2025100512102035000_15.9.e102044.75","doi-asserted-by":"crossref","first-page":"632","DOI":"10.47102\/annals-acadmedsg.V42N12p632","article-title":"Quality of Care of Patients with Chronic Kidney Disease in National Healthcare Group Polyclinics from 2007 to 2011","volume":"42","author":"Ang","year":"2013","journal-title":"Ann Acad Med Singap"},{"key":"2025100512102035000_15.9.e102044.76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180977","article-title":"The impact of the quality of care and other factors on progression of chronic kidney disease in Thai patients with Type 2 Diabetes Mellitus: A nationwide cohort study","volume":"12","author":"Sonthon","year":"2017","journal-title":"PLoS ONE"},{"key":"2025100512102035000_15.9.e102044.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2013.11.004"},{"key":"2025100512102035000_15.9.e102044.78","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11096-016-0298-1","article-title":"Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector","volume":"38","author":"Meuwesen","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"2025100512102035000_15.9.e102044.79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115058","article-title":"International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps","volume":"129","author":"Liabeuf","year":"2019","journal-title":"Bone"},{"key":"2025100512102035000_15.9.e102044.80","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.kint.2019.04.032","article-title":"Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease","volume":"96","author":"Alencar de Pinho","year":"2019","journal-title":"Kidney Int"},{"key":"2025100512102035000_15.9.e102044.81","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015987","article-title":"The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2025100512102035000_15.9.e102044.82","volume-title":"Diabetes care","volume":"46","author":"Care","year":"2023"},{"key":"2025100512102035000_15.9.e102044.83","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26230","article-title":"Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease","volume":"6","author":"Chu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025100512102035000_15.9.e102044.84","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ndt\/gfac283","article-title":"Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease","volume":"38","author":"Nee","year":"2023","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-102044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:11:02Z","timestamp":1759691462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-102044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,4]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2025-102044"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-102044","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}